FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven LaRosa

Research Profile

Concepts & Ideas

Chemicals & Drugs

Procedures

Double-Blind Method

Disorders

Living Beings

Burkholderia pseudomallei

Co-author Network

Publications

TOP 3
Steven M Opal; Jan Pachl; Claus Peckelsen; Dominique Perrotin; Mary B Roberts; Daniel P Rossignol; Roland Schein; Takeshi Takahashi; Mark Tidswell; Marc Van Nuffelen; Jean-Louis Vincent; Janice L Wheeler; Xavier Wittebole; Naoki Aikawa; Derek C Angus; Chia-Sheng Chang; Edward Cordasco; Thierry Dugernier; Bruno Francois; Jogadish Gogate; Luis Jauregui; Andre C Kalil; Kenneth Krell; Steven P LaRosa; Pierre-François Laterre; Melvyn Lynn; Tatsuya Maruyama; Jean-Paul Mira; Sandra Oeyen
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial.
Steven P LaRosa
Activated protein C for H1N1 influenza? More work to do!
Steven P LaRosa; Steven M Opal; Barbara G Utterback; Sau Chi Betty Yan; Jeffrey D Helterbrand; Andrew J H Simpson; Wipada Chaowagul; Nicholas J White; Charles J Fisher
Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven LaRosa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Steven M Opal; Jan Pachl; Claus Peckelsen; Dominique Perrotin; Mary B Roberts; Daniel P Rossignol; Roland Schein; Takeshi Takahashi; Mark Tidswell; Marc Van Nuffelen; Jean-Louis Vincent; Janice L Wheeler; Xavier Wittebole; Naoki Aikawa; Derek C Angus; Chia-Sheng Chang; Edward Cordasco; Thierry Dugernier; Bruno Francois; Jogadish Gogate; Luis Jauregui; Andre C Kalil; Kenneth Krell; Steven P LaRosa; Pierre-François Laterre; Melvyn Lynn; Tatsuya Maruyama; Jean-Paul Mira; Sandra Oeyen
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial.
JAMA : the journal of the American Medical Association 2013;309(11):1154-62.
2010: Steven P LaRosa
Activated protein C for H1N1 influenza? More work to do!
Critical care (London, England) 2010;14(3):156.
2006: Steven P LaRosa; Steven M Opal; Barbara G Utterback; Sau Chi Betty Yan; Jeffrey D Helterbrand; Andrew J H Simpson; Wipada Chaowagul; Nicholas J White; Charles J Fisher
Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2006;10(1):25-31.
2005: Steven P LaRosa; Steven M Opal
Tissue factor pathway inhibitor and antithrombin trial results.
Critical care clinics 2005;21(3):433-48.
2003: Jean-François Dhainaut; Pierre-François Laterre; Steven P LaRosa; Howard Levy; Gary E Garber; Darell E Heiselman; Gary T Kinasewitz; R Bruce Light; Peter Morris; Roland M H Schein; Jean-Pierre Sollet; Becky M Bates; Barbara G Utterback; Dennis G Maki
The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): role, methodology, and results.
Critical care medicine 2003;31(9):2291-301.
2003: Steven M Opal; Gary E Garber; Steven P LaRosa; Dennis G Maki; Ross Freebairn; Gary T Kinasewitz; Jean-François Dhainaut; S Betty Yan; Mark D Williams; Delores E Graham; David Nelson; Howard Levy; gordon bernard
Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(1):50-8.
2001: gordon bernard; Jean-Louis Vincent; Pierre-François Laterre; Steven P LaRosa; Jean-François Dhainaut; A Lopez-Rodriguez; Jay S Steingrub; Gary E Garber; Jeffrey D Helterbrand; E Wesley Ely; Charles J Fisher
Efficacy and safety of recombinant human activated protein C for severe sepsis.
The New England journal of medicine 2001;344(10):699-709.